Akari Therapeutics Plc organizacji ROCE
Jaka jest wartość ROCE organizacji Akari Therapeutics Plc?
Wartość ROCE organizacji Akari Therapeutics Plc to -220.95%
Jaka jest definicja ROCE?
Zwrot z zaangażowanego kapitału Return on capital employed (ROCE) to wskaźnik finansowy, który mierzy zyskowność przedsiębiorstwa i efektywność, z jaką wykorzystywany jest jego kapitał.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE firm w Health Care sektor na NASDAQ w porównaniu do Akari Therapeutics Plc
Czym się zajmuję organizacja Akari Therapeutics Plc?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Firmy z roce podobne do Akari Therapeutics Plc
- Wartość ROCE organizacji BioCardia to -224.64%
- Wartość ROCE organizacji Sunworks Inc to -223.47%
- Wartość ROCE organizacji Soligenix Inc to -223.00%
- Wartość ROCE organizacji Katoro Gold plc to -222.81%
- Wartość ROCE organizacji DelMar Pharmaceuticals to -222.47%
- Wartość ROCE organizacji Applied Therapeutics to -222.43%
- Wartość ROCE organizacji Akari Therapeutics Plc to -220.95%
- Wartość ROCE organizacji Dore Copper Mining to -220.90%
- Wartość ROCE organizacji Applied Genetic Technologies Corp to -219.90%
- Wartość ROCE organizacji Intrusion to -219.55%
- Wartość ROCE organizacji Galera Therapeutics Inc to -218.63%
- Wartość ROCE organizacji Lumos Pharma Inc to -217.72%
- Wartość ROCE organizacji AutoWeb Inc to -217.47%